Bone loss in adults with cystic fibrosis: prevalence, associated factors, and usefulness of biological markers
- PMID: 21733729
- DOI: 10.1016/j.jbspin.2011.05.009
Bone loss in adults with cystic fibrosis: prevalence, associated factors, and usefulness of biological markers
Abstract
Background: Osteoporosis is a common complication of cystic fibrosis.
Objective: To determine the prevalence of osteopenia and osteoporosis in adults with cystic fibrosis and to look for factors associated with low bone mineral density (BMD) values.
Methods: During this prospective 2-year study, we collected clinical data (history, body mass index, and treatments) and laboratory data (nutritional and hormonal status, markers for inflammation and bone turnover, and calcium and phosphate levels). Lung function tests and a 6-meter walking test were performed. BMD was measured at the spine, total hip, and femoral neck.
Results: We included 55 patients (31 women) with a mean age of 31.9 years; 14 were homozygous and 25 heterozygous for the deltaF508 mutation and 20 (36%) had a history of fractures. BMD values indicated osteopenia in 32 (58.2%) patients and osteoporosis in 11 (20%) patients at one or more measurement sites. At all three sites, BMD values correlated with the body mass index, forced vital capacity as % predicted, and forced expiratory volume in 1 s as % predicted; at the femoral neck and total hip, BMD values correlated with the 6-meter walking test result and grip strength.
Conclusion: BMD was low in 78.2% of adults with cystic fibrosis. Three factors reflecting lung disease severity were associated with low BMD values, namely, respiratory function, physical function (walking test and grip strength), and nutritional status.
Copyright © 2011 Société française de rhumatologie. Published by Elsevier SAS. All rights reserved.
Similar articles
-
Reduced bone density in cystic fibrosis: DeltaF508 mutation is an independent risk factor.Eur Respir J. 2005 Jan;25(1):54-61. doi: 10.1183/09031936.04.00050204. Eur Respir J. 2005. PMID: 15640323
-
Osteoporosis and osteopenia in adults and adolescents with cystic fibrosis: prevalence and associated factors.Thorax. 2000 Sep;55(9):798-804. doi: 10.1136/thorax.55.9.798. Thorax. 2000. PMID: 10950902 Free PMC article.
-
Bone mineral density and quantitative ultrasound in adults with cystic fibrosis.Eur J Endocrinol. 2002 Apr;146(4):531-6. doi: 10.1530/eje.0.1460531. Eur J Endocrinol. 2002. PMID: 11916622
-
The prevalence of osteoporosis, osteopenia, and fractures among adults with cystic fibrosis: a systematic literature review with meta-analysis.Calcif Tissue Int. 2010 Jan;86(1):1-7. doi: 10.1007/s00223-009-9316-9. Epub 2009 Dec 1. Calcif Tissue Int. 2010. PMID: 19949942 Review.
-
Bone disease in cystic fibrosis: what's new?Joint Bone Spine. 2011 Oct;78(5):445-50. doi: 10.1016/j.jbspin.2010.11.015. Epub 2011 Jan 12. Joint Bone Spine. 2011. PMID: 21233000 Review.
Cited by
-
Lung transplantation for cystic fibrosis: results, indications, complications, and controversies.Semin Respir Crit Care Med. 2015 Apr;36(2):299-320. doi: 10.1055/s-0035-1547347. Epub 2015 Mar 31. Semin Respir Crit Care Med. 2015. PMID: 25826595 Free PMC article. Review.
-
Prevalence and Risk Factors for Low Bone Mineral Density in Adults With Cystic Fibrosis.JBMR Plus. 2022 Sep 16;6(11):e10666. doi: 10.1002/jbm4.10666. eCollection 2022 Nov. JBMR Plus. 2022. PMID: 36398108 Free PMC article.
-
Increased NF-κB Activity and Decreased Wnt/β-Catenin Signaling Mediate Reduced Osteoblast Differentiation and Function in ΔF508 Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Mice.J Biol Chem. 2015 Jul 17;290(29):18009-18017. doi: 10.1074/jbc.M115.646208. Epub 2015 Jun 9. J Biol Chem. 2015. PMID: 26060255 Free PMC article.
-
Bisphosphonates for osteoporosis in people with cystic fibrosis.Cochrane Database Syst Rev. 2023 Jan 10;1(1):CD002010. doi: 10.1002/14651858.CD002010.pub5. Cochrane Database Syst Rev. 2023. PMID: 36625789 Free PMC article. Review.
-
Young adults with cystic fibrosis have altered trabecular microstructure by ITS-based morphological analysis.Osteoporos Int. 2016 Aug;27(8):2497-505. doi: 10.1007/s00198-016-3557-z. Epub 2016 Mar 7. Osteoporos Int. 2016. PMID: 26952010 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical